Early Removal of the Urethral Catheter Following Trans-urethral Resection of Prostate
Early Versus Delayed Removal of the Urethral Catheter After Trans Urethral, Randomized Clinical Trial.
1 other identifier
observational
200
1 country
1
Brief Summary
Transurethral resection of prostate is the gold standard operation for bladder outflow obstruction due to benign prostatic enlargement. However, catheter removal day is variable. The objective of this study is to compare early and delayed catheter removal groups in terms of, urinary retention after catheter removal, length of hospital stay, weight of resected prostate, duration of resection, peri-operative blood transfusion, and postoperative complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 30, 2019
CompletedFirst Submitted
Initial submission to the registry
April 16, 2020
CompletedFirst Posted
Study publicly available on registry
April 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2021
CompletedAugust 20, 2021
August 1, 2021
10 months
April 16, 2020
August 18, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
urinary retention
inability to void
after 3 months.
Secondary Outcomes (1)
Lower urinary tract symptoms
after 3 months.
Study Arms (2)
group A- early catheter removal)
in group A, we will remove the catheter after 24 h.
Group B- delayed catheter removal
In group B, we will remove the catheter after 48 h.
Interventions
in group A, we will remove the catheter after 24 h. In group B, we will remove the catheter after 48 h.
Eligibility Criteria
200 adult males from urology clinic atJordan university hospital, with benign prostate hyperplasia who undergo trans-urethral resection of the prostae will be included in this study,
You may qualify if:
- \- All men with benign prostate hyperplasia who planned to undergo TURP will be included in this study.
You may not qualify if:
- Large post void residual urine.
- Simultaneous internal urethrotomy and TURP.
- Uncontrolled Diabetes Mellitus (DM).
- Cerebrovascular accident accident (CVA).
- Spinal cord injury.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saddam Al Demour
Amman, 11942, Jordan
Related Publications (1)
Demour SA, Al-Zubi MT, Ababneh M, Al-Rawashdah SF, Ahmad M. A randomized clinical trial: timing of indwelling urethral catheter removal following transurethral resection of prostate. Future Sci OA. 2024 May 20;10(1):FSO927. doi: 10.2144/fsoa-2023-0195. eCollection 2024.
PMID: 38827798DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Saddam Al Demour, MD
Jordan University Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
April 16, 2020
First Posted
April 27, 2020
Study Start
June 30, 2019
Primary Completion
April 30, 2020
Study Completion
April 30, 2021
Last Updated
August 20, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share